Hayat Pharmaceutical Industries Co. PLC reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was JOD 5 million compared to JOD 4.34 million a year ago. Net income was JOD 1.25 million compared to JOD 1.06 million a year ago. Basic earnings per share from continuing operations was JOD 0.13 compared to JOD 0.11 a year ago.
For the nine months, sales was JOD 12.76 million compared to JOD 13.63 million a year ago. Net income was JOD 2.8 million compared to JOD 3.62 million a year ago. Basic earnings per share from continuing operations was JOD 0.29 compared to JOD 0.38 a year ago.